Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nina Orlova

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Journal of Virology|September 16, 2011
Persistent infection drives the development of CD8+ T cells specific for late lytic infection antigens in lymphocryptovirus-infected macaques and Epstein-Barr virus-infected humansNina Orlova, Fred Wang, Mark H Fogg
Journal of Virology|November 19, 2010
Cloning of the Epstein-Barr virus-related rhesus lymphocryptovirus as a bacterial artificial chromosome: a loss-of-function mutation of the rhBARF1 immune evasion geneMakoto Ohashi, Nina Orlova, Carol Quink, et al.
Clinical and Vaccine Immunology : CVI|July 8, 2011
Antibodies to lytic infection proteins in lymphocryptovirus-infected rhesus macaques: a model for humoral immune responses to epstein-barr virus infectionNina Orlova, Mark H Fogg, Angela Carville, et al.
Seminars in Immunopathology|February 21, 2020
Human unconventional T cells in Plasmodium falciparum infectionMathias Schmaler, Nina Orlova-Fink, Tobias Rutishauser, et al.
Plos Pathogens|January 10, 2013
An Epstein-Barr virus encoded inhibitor of Colony Stimulating Factor-1 signaling is an important determinant for acute and persistent EBV infectionMakoto Ohashi, Mark H Fogg, Nina Orlova, et al.
Computer Methods and Programs in Biomedicine|December 1, 2018
Initializing a hospital-wide data quality program. The AP-HP experienceChristel Daniel, Patricia Serre, Nina Orlova, et al.
BMJ Evidence-Based Medicine|December 14, 2020
Inactivated trivalent influenza vaccination is associated with lower mortality among patients with COVID-19 in BrazilGünther Fink, Nina Orlova-Fink, Tobias Schindler, et al.
AIDS (London, England)|September 1, 2017
Preferential susceptibility of Th9 and Th2 CD4+ T cells to X4-tropic HIV-1 infectionNina Orlova-Fink, Fatema Z Chowdhury, Xiaoming Sun, et al.
International Heart Journal|December 23, 2016
Gene-Targeted Analysis of Clinically Diagnosed Long QT Russian FamiliesPaolo Enrico Maltese, Nina Orlova, Eugenia Krasikova, et al.
BMC Research Notes|September 8, 2019
Safety and tolerance of lymph node biopsies from chronic HIV-1 volunteers in rural TanzaniaCatherine Gerald Mkindi, Elias Antony Marandu, Ngisi Masawa, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Journal of Virology|September 16, 2011
Persistent infection drives the development of CD8+ T cells specific for late lytic infection antigens in lymphocryptovirus-infected macaques and Epstein-Barr virus-infected humansNina Orlova, Fred Wang, Mark H Fogg
Journal of Virology|November 19, 2010
Cloning of the Epstein-Barr virus-related rhesus lymphocryptovirus as a bacterial artificial chromosome: a loss-of-function mutation of the rhBARF1 immune evasion geneMakoto Ohashi, Nina Orlova, Carol Quink, et al.
Clinical and Vaccine Immunology : CVI|July 8, 2011
Antibodies to lytic infection proteins in lymphocryptovirus-infected rhesus macaques: a model for humoral immune responses to epstein-barr virus infectionNina Orlova, Mark H Fogg, Angela Carville, et al.
Seminars in Immunopathology|February 21, 2020
Human unconventional T cells in Plasmodium falciparum infectionMathias Schmaler, Nina Orlova-Fink, Tobias Rutishauser, et al.
Plos Pathogens|January 10, 2013
An Epstein-Barr virus encoded inhibitor of Colony Stimulating Factor-1 signaling is an important determinant for acute and persistent EBV infectionMakoto Ohashi, Mark H Fogg, Nina Orlova, et al.
Computer Methods and Programs in Biomedicine|December 1, 2018
Initializing a hospital-wide data quality program. The AP-HP experienceChristel Daniel, Patricia Serre, Nina Orlova, et al.
BMJ Evidence-Based Medicine|December 14, 2020
Inactivated trivalent influenza vaccination is associated with lower mortality among patients with COVID-19 in BrazilGünther Fink, Nina Orlova-Fink, Tobias Schindler, et al.
AIDS (London, England)|September 1, 2017
Preferential susceptibility of Th9 and Th2 CD4+ T cells to X4-tropic HIV-1 infectionNina Orlova-Fink, Fatema Z Chowdhury, Xiaoming Sun, et al.
International Heart Journal|December 23, 2016
Gene-Targeted Analysis of Clinically Diagnosed Long QT Russian FamiliesPaolo Enrico Maltese, Nina Orlova, Eugenia Krasikova, et al.
BMC Research Notes|September 8, 2019
Safety and tolerance of lymph node biopsies from chronic HIV-1 volunteers in rural TanzaniaCatherine Gerald Mkindi, Elias Antony Marandu, Ngisi Masawa, et al.
Pageof 2